Expression and prognostic value of plasminogen activator inhibitor type 1 in node-negative breast cancer

By Wang Bin  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 6, 2008-06 ,pp. : 339-343

Springer Publishing Company

Access to resources Recommend Favorite

Aberrant expression of cyclin E in low-risk node negative breast cancer

By Ahlin Cecilia   Gruhne Bettina   Holmqvist Marit   Zetterberg Anders   Fjallskog Marie-Louise  

Acta Oncologica, Vol. 47, Iss. 8, 2008-01 ,pp. : 1539-1545

Informa Healthcare

Access to resources Recommend Favorite

Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients

By Chung Hyun   Rha Sun   Park Joon   Yoo Nae   Kim Joo   Roh Jae   Min Jin   Lee Kyong   Kim Byung   Kim Jin  

Breast Cancer Research and Treatment, Vol. 49, Iss. 1, 1998-05 ,pp. : 41-50

Springer Publishing Company

Access to resources Recommend Favorite

T1 Breast Cancer: Identification of Patients at Low Risk of Axillary Lymph Node Metastases

By Bader A.A.  

Breast Cancer Research and Treatment, Vol. 76, Iss. 1, 2002-11 ,pp. : 11-17

Springer Publishing Company

Access to resources Recommend Favorite

Lack of association between level of Plasminogen Activator Inhibitor-1 and estimates of tumor angiogenesis in early breast cancer

By Offersen Birgitte Vrou   Riisbro Rikke   Knoop Ann   Brünner Nils   Overgaard Jens   Group on behalf of the Danish Breast Cancer Cooperative   Committee Tumor Biology  

Acta Oncologica, Vol. 46, Iss. 6, 2007-01 ,pp. : 782-791

Informa Healthcare

Access to resources Recommend Favorite